000 01270 a2200313 4500
005 20250517120901.0
264 0 _c20170920
008 201709s 0 0 eng d
022 _a1521-1878
024 7 _a10.1002/bies.201600070
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHalsall, John A
245 0 0 _aHistone deacetylase inhibitors for cancer therapy: An evolutionarily ancient resistance response may explain their limited success.
_h[electronic resource]
260 _bBioEssays : news and reviews in molecular, cellular and developmental biology
_c11 2016
300 _a1102-1110 p.
_bdigital
500 _aPublication Type: Journal Article; Review; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aFemale
650 0 4 _aHistone Deacetylase Inhibitors
_xpharmacology
650 0 4 _aHistone Deacetylases
_xdrug effects
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMutation
650 0 4 _aNeoplasms
_xdrug therapy
650 0 4 _aSignal Transduction
_xdrug effects
700 1 _aTurner, Bryan M
773 0 _tBioEssays : news and reviews in molecular, cellular and developmental biology
_gvol. 38
_gno. 11
_gp. 1102-1110
856 4 0 _uhttps://doi.org/10.1002/bies.201600070
_zAvailable from publisher's website
999 _c26495661
_d26495661